Quantum-Si (NASDAQ:QSI) Announces Earnings Results

Quantum-Si (NASDAQ:QSI) issued its quarterly earnings results on Tuesday. The company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.03, reports. The company had revenue of $0.79 million during the quarter, compared to analysts’ expectations of $1.06 million. Quantum-Si had a negative net margin of 3,968.84% and a negative return on equity of 35.42%.

Quantum-Si Stock Performance

Quantum-Si stock opened at $0.79 on Thursday. The stock has a 50-day simple moving average of $0.86 and a 200 day simple moving average of $1.12. The stock has a market capitalization of $112.65 million, a P/E ratio of -1.24 and a beta of 2.89. Quantum-Si has a 52 week low of $0.70 and a 52 week high of $2.43.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in QSI. Bleakley Financial Group LLC bought a new position in Quantum-Si in the 1st quarter valued at about $28,000. Vanguard Group Inc. increased its stake in shares of Quantum-Si by 1.6% during the first quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company’s stock worth $10,442,000 after purchasing an additional 82,463 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in Quantum-Si by 11.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 59,727 shares of the company’s stock worth $118,000 after purchasing an additional 5,945 shares during the last quarter. Public Employees Retirement System of Ohio bought a new stake in Quantum-Si in the 1st quarter valued at $27,000. Finally, Jacobs Levy Equity Management Inc. acquired a new position in Quantum-Si in the 1st quarter valued at $998,000. 39.90% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently commented on QSI shares. HC Wainwright reissued a “buy” rating and set a $4.00 price target on shares of Quantum-Si in a research report on Wednesday. Canaccord Genuity Group cut their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.